eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	SCOPUS BIOPHARMA INC.
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A biotechnology company focused on developing novel therapeutics targeting the endocannabinoid system. This system is critical for maintaining overall human health by modulating key functions within the body, including those relating to the immune, metabolic and nervous systems.
Lead Underwriter	The Benchmark Company, LLC
Co-Managers	N/A
Initial Shares	700,000
Revised Initial Shares	N/A
Initial Price	$6.50-$6.50
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A